The impact of an antireflux procedure on intestinal metaplasia of the cardia

被引:69
作者
DeMeester, SR
Campos, GMR
DeMeester, TR
Bremner, CG
Hagen, JA
Peters, JH
Crookes, PF
机构
[1] Univ So Calif, Sch Med, Dept Surg, Sect Thorac & Foregut Surg, Los Angeles, CA 90033 USA
[2] Univ So Calif, Sch Med, Dept Cardiothorac Surg, Sect Thorac & Foregut Surg, Los Angeles, CA 90033 USA
关键词
D O I
10.1097/00000658-199810000-00011
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective The aim of this study was to determine whether antireflux surgery is more effective in producing loss of intestinal metaplasia located only at the gastroesophageal junction than ii has been in patients with intestinal metaplasia extending up into the distal esophagus, Summary Background Data Biopsies of a normal appearing gastroesophageal junction will demonstrate cardiac mucosa containing goblet cells-the hallmark of intestinal metaplasia-in 10% to 15% of patients who are evaluated for symptoms of gastroesophageal reflux. The incidence of adenocarcinoma of the esophagus and cardia is rising faster than any other cancer in America, and most of these cancers are found adjacent to areas of intestinal metaplasia. Antireflux surgery in patients with Barrett's esophagus may provide protection from progression to dysplasia and cancer; however, it does not reliably cause regression of the intestinal metaplasia, Less is known about the potential for intestinal metaplasia limited to the cardia (CIM) to regress. Methods Sixty patients with intestinal metaplasia of the esophagus or cardia had antireflux surgery. Patients in the intestinal (CIM) group (n = 15) had no endoscopically visible seg ment of columnar epithelium. Patients in the Barrett's group (n = 45) had columnar epithelium visible within the esophagus, Median follow-up was 25 months in each group, Results Postoperative biopsies showed complete loss of intestinal metaplasia in 73% of the patients with CIM compared with 4.4% of the patients with Barrett's, Low-grade dysplasia, present in 10 patients preoperatively, regressed in 7 pa tien ts (70%), No patient progressed to high-grade dysplasia or cancer. Conclusions Loss of intestinal metaplasia after antireflux surgery is rare in patients with Barrett's, but occurred in most patients with CIM. This suggests that cardiac epithelium is dynamic and that microscopic areas of intestinal metaplasia are able to regress much more frequently than longer, visible segments of intestinal metaplasia.
引用
收藏
页码:547 / 553
页数:7
相关论文
共 24 条
[1]   RISING INCIDENCE OF ADENOCARCINOMA OF THE ESOPHAGUS AND GASTRIC CARDIA [J].
BLOT, WJ ;
DEVESA, SS ;
KNELLER, RW ;
FRAUMENI, JF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (10) :1287-1289
[2]  
Chandrasoma P, 1997, Semin Thorac Cardiovasc Surg, V9, P270
[3]  
Clark G W, 1997, J Gastrointest Surg, V1, P113
[4]  
CLARK GWB, 1994, ARCH SURG-CHICAGO, V129, P609
[5]   LOCATION OF THE LOWER ESOPHAGEAL SPHINCTER AND THE SQUAMOUS COLUMNAR MUCOSAL JUNCTION IN 109 HEALTHY CONTROLS AND 778 PATIENTS WITH DIFFERENT DEGREES OF ENDOSCOPIC ESOPHAGITIS [J].
CSENDES, A ;
MALUENDA, F ;
BRAGHETTO, I ;
CSENDES, P ;
HENRIQUEZ, A ;
QUESADA, MS .
GUT, 1993, 34 (01) :21-27
[6]  
DeMeester S R, 1997, Semin Thorac Cardiovasc Surg, V9, P279
[7]   SURGICAL THERAPY IN BARRETTS-ESOPHAGUS [J].
DEMEESTER, TR ;
ATTWOOD, SEA ;
SMYRK, TC ;
THERKILDSEN, DH ;
HINDER, RA .
ANNALS OF SURGERY, 1990, 212 (04) :528-542
[8]   Duodenogastric Reflux Potentiates the Injurious Effects of Gastroesophageal Reflux [J].
Fein M. ;
Ireland A.P. ;
Ritter M.P. ;
Peters J.H. ;
Hagen J.A. ;
Bremner C.G. ;
DeMeester T.R. .
Journal of Gastrointestinal Surgery, 1997, 1 (1) :27-33
[9]  
HAGGITT RC, 1978, AM J CLIN PATHOL, V70, P1
[10]   PREVALENCE AND CHARACTERISTICS OF BARRETT ESOPHAGUS IN PATIENTS WITH ADENOCARCINOMA OF THE ESOPHAGUS OR ESOPHAGOGASTRIC JUNCTION [J].
HAMILTON, SR ;
SMITH, RRL ;
CAMERON, JL .
HUMAN PATHOLOGY, 1988, 19 (08) :942-948